logo
Plus   Neg
Share
Email

Die Welt Newspaper: Airbus Sees 2020/2021 Deliveries 40% Below Original Estimates

Speaking at the WELT discussion, Airbus Group N.V. (EADSF.PK,EADSY.PK) Chief Executive Officer Guillaume Faury said the company assumes that production and deliveries for the next two years will be 40 percent below prior estimates. Volume levels are anticipated to hit the previous numbers by 2025, at the earliest.

In April, Airbus reduced commercial aircraft production by a third citing lower demand due to the Covid-19 pandemic. Production of A320 narrowbody aircraft was curtailed to 40 per month, from original production of 60 per month. Reportedly, the company now expects its A320 fleet to gradually raise production from 2022/2023.

As per media reports, Airbus CEO has already informed its employees that the company's survival is at stake without any immediate action, which may include major job cuts.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration on Saturday authorized Johnson & Johnson's (JNJ) single-dose COVID-19 vaccine for emergency use. It is the first single-shot COVID-19 vaccine and the third COVID-19 vaccine for emergency use in the U.S. - the other two being Pfizer/BioNTech's BNT162b2 and Moderna's mRNA-1273. The U.S. Food and Drug Administration said that it will rapidly work toward finalization and issuance of an emergency use authorization of Johnson & Johnson's (JNJ) single-shot COVID-19 vaccine candidate. Billionaire Warren Buffett's Berkshire Hathaway Inc. (BRK.A, BRK.B) reported that its fourth-quarter net earnings attributable to shareholders rose 23 percent to $35.84 billion from last year's $29.16 billion, with earnings per share improving to $23,015 per Class A share from $17,909 per Class A share in the prior year.
Follow RTT